The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial

The Long-Term Efficacy and Safety of a Grass Allergen Tablet for Sublingual Immunotherapy: Findings from a 3-yr Clinical Trial

Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S75-S75
Hauptverfasser: Emminger, W, Dahl, R, Kapp, A, Colombo, G, Rak, S, Broge, L, Durham, S
Format: Artikel
Sprache:eng
Schlagworte:
Allergy and Immunology
Clinical trials
Drug therapy
Grasses
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Safety and efficacy results were obtained after 3 years of continuous treatment with grass allergen tablets (Grazax® 75,000 SQ-T (2,800 BAU), Phleum pratense, ALK-Abelló A/S) previously shown to be an efficacious and well-tolerated treatment for grass pollen allergy.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.297